医学
内科学
食欲不振
不利影响
临床终点
人口
临床试验
肺癌
ROS1型
胃肠病学
临床研究阶段
外科
癌症
腺癌
环境卫生
作者
M. Pérol,Wei Li,Nathan A. Pennell,Geoffrey Liu,Yuichiro Ohe,Filippo de Braud,Misako Nagasaka,Enriqueta Felip,Anwen Xiong,Yongchang Zhang,Huijie Fan,Xicheng Wang,Shuanglian Li,Rose Lai,Fei-Wu Ran,Xianyu Zhang,Wenfeng Chen,Lyudmila Bazhenova,Caicun Zhou
摘要
Taletrectinib showed a high response rate with durable responses, robust IC activity, prolonged PFS, favorable safety, and low rates of neurologic adverse events in TKI-naïve and pretreated patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
caigou
GingerF
潇洒的惋清
Rainyin
IvanMcRae
嘻嘻哈哈
vetboy
AllRightReserved
OK
无极微光
sanvva
张欢馨
HFH
互助
Carrie
印第安老斑鸠
想起了拥抱
cc
Kimin
初景
皖公网安备34019202002308
